insomnia on semaglutide and Sleep: Can the Medication Affect Your Rest Quality? Semaglutide and its impact on

(2023) "Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial" The Lancet, 402(10403) 4

Average loss during this window ranges from 5-10% of baseline weight, though individual variation remains wide

They exert a direct neuromuscular-blocking effect at the acetylcholine receptor or presynaptic terminal, leading to increased muscle weakness or even respiratory failure in susceptible patients

Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression